drugset / Trial / NCT00095147
Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this clinical research study is to learn if Abatacept or Infliximab in combination with Methotrexate demonstrate a greater reduction in disease activity over placebo.
Timeline
- Start
- 2005-02
- Primary completion
- 2009-07
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Abatacept | Other / unclassified | 10 mg/kg | Intravenous |
| Comparator | Infliximab | Monoclonal antibody | 3 mg/kg | Intravenous |
| Comparator | Methotrexate | Small molecule | — | — |